AMMONIA N 13

Post-LOE

ammonia n-13

United Therapeutics

ANDAINTRAVENOUSINJECTABLE

Approved

Jul 2021

Lifecycle

Post-LOE

Competitive Pressure

30/100

Mechanism of Action

Radiopharmaceutical Activity

Pharmacologic Class:

Radioactive Diagnostic Agent

Company

United Therapeutics

MD - Silver Spring

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers